BACKGROUND: The distribution of the emitter substance in 106Ru eye plaques is usually assumed to be homogeneous for treatment planning purposes. However, this distribution is never homogeneous, and it widely differs from plaque to plaque due to manufacturing factors. METHODS: By Monte Carlo simulation of radiation transport, we study the absorbed dose distribution obtained from the specific CCA1364 and CCB1256 106Ru plaques, whose actual emitter distributions were measured. The idealized, homogeneous CCA and CCB plaques are also simulated. RESULTS: The largest discrepancy in depth dose distribution observed between the heterogeneous and the homogeneous plaques was 7.9 and 23.7% for the CCA and CCB plaques, respectively. In terms of isodose lines, the line referring to 100% of the reference dose penetrates 0.2 and 1.8 mm deeper in the case of heterogeneous CCA and CCB plaques, respectively, with respect to the homogeneous counterpart. CONCLUSIONS: The observed differences in absorbed dose distributions obtained from heterogeneous and homogeneous plaques are clinically irrelevant if the plaques are used with a lateral safety margin of at least 2 mm. However, these differences may be relevant if the plaques are used in eccentric positioning.
BACKGROUND: The distribution of the emitter substance in 106Ru eye plaques is usually assumed to be homogeneous for treatment planning purposes. However, this distribution is never homogeneous, and it widely differs from plaque to plaque due to manufacturing factors. METHODS: By Monte Carlo simulation of radiation transport, we study the absorbed dose distribution obtained from the specific CCA1364 and CCB1256 106Ru plaques, whose actual emitter distributions were measured. The idealized, homogeneous CCA and CCB plaques are also simulated. RESULTS: The largest discrepancy in depth dose distribution observed between the heterogeneous and the homogeneous plaques was 7.9 and 23.7% for the CCA and CCB plaques, respectively. In terms of isodose lines, the line referring to 100% of the reference dose penetrates 0.2 and 1.8 mm deeper in the case of heterogeneous CCA and CCB plaques, respectively, with respect to the homogeneous counterpart. CONCLUSIONS: The observed differences in absorbed dose distributions obtained from heterogeneous and homogeneous plaques are clinically irrelevant if the plaques are used with a lateral safety margin of at least 2 mm. However, these differences may be relevant if the plaques are used in eccentric positioning.
Keywords:
Beta emitter; Brachytherapy; Dosimetry; Eye plaques; Monte Carlo simulation; Ruthenium; Simulation
Authors: R E Tjho-Heslinga; J Davelaar; H M Kemme; H de Vroome; J A Oosterhuis; J C Bleeker; J W Leer Journal: Radiother Oncol Date: 1999-11 Impact factor: 6.280
Authors: R E Tjho-Heslinga; H M Kakebeeke-Kemme; J Davelaar; H de Vroome; J C Bleeker; J A Oosterhuis; J W Leer Journal: Radiother Oncol Date: 1993-10 Impact factor: 6.280
Authors: Erik Stöckel; Marion Eichmann; Dirk Flühs; Holger Sommer; Eva Biewald; Norbert Bornfeld; Bernhard Spaan; Wolfgang Sauerwein Journal: Ocul Oncol Pathol Date: 2017-09-16
Authors: Francisco J Zaragoza; Marion Eichmann; Dirk Flühs; Andrea Wittig; Wolfgang Sauerwein; Lorenzo Brualla Journal: Ocul Oncol Pathol Date: 2018-10-15
Authors: Charlotte A Espensen; Ane L Appelt; Lotte S Fog; Anita B Gothelf; Juliette Thariat; Jens F Kiilgaard Journal: Cancers (Basel) Date: 2019-08-06 Impact factor: 6.639